000			02257 a2200589 4500
005			20250515020859.0
264		0	_c20060811
008			200608s 0 0 eng d
022			_a0014-4886
024	7		_a10.1016/j.expneurol.2006.01.033 _2doi
040			_aNLM _beng _cNLM
100	1		_aLeinhase, Iris
245	0	0	_aPharmacological complement inhibition at the C3 convertase level promotes neuronal survival, neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injury. _h[electronic resource]
260			_bExperimental neurology _cJun 2006
300			_a454-64 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aBehavior, Animal _xdrug effects
650	0	4	_aBlotting, Western _xmethods
650	0	4	_aBrain _xdrug effects
650	0	4	_aBrain Injuries _xdrug therapy
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aComplement System Proteins _xgenetics
650	0	4	_aDisease Models, Animal
650	0	4	_aGene Expression _xdrug effects
650	0	4	_aImmunohistochemistry _xmethods
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aNeurons _xdrug effects
650	0	4	_aNeuroprotective Agents _xadministration & dosage
650	0	4	_aProto-Oncogene Proteins c-bcl-2 _xgenetics
650	0	4	_aPsychomotor Performance _xdrug effects
650	0	4	_aRNA, Messenger _xmetabolism
650	0	4	_aReceptors, Complement _xadministration & dosage
650	0	4	_aReceptors, Complement 3b
650	0	4	_aReverse Transcriptase Polymerase Chain Reaction _xmethods
650	0	4	_aTime Factors
650	0	4	_aTrauma Severity Indices
700	1		_aSchmidt, Oliver I
700	1		_aThurman, Joshua M
700	1		_aHossini, Amir M
700	1		_aRozanski, Michal
700	1		_aTaha, Mohy E
700	1		_aScheffler, Alice
700	1		_aJohn, Thilo
700	1		_aSmith, Wade R
700	1		_aHolers, V Michael
700	1		_aStahel, Philip F
773	0		_tExperimental neurology _gvol. 199 _gno. 2 _gp. 454-64
856	4	0	_uhttps://doi.org/10.1016/j.expneurol.2006.01.033 _zAvailable from publisher's website
999			_c16154054 _d16154054